STUDY: Semaglutide Seems to Reduce MACE & Death Rates for Certain Participants
hyee_para2024-09-16T13:17:35+00:00Semaglutide Seems to Reduce MACE & Death Rates for Certain Participants SOURCE: Semaglutide Reduces MACE, Death in Participants With CVD, Overweight/Obesity, and Impaired Kidney Function A recent subgroup analysis from the SELECT trial has demonstrated that semaglutide (Wegovy) significantly reduces major cardiac events, including death, in adults with overweight or obesity and cardiovascular disease [...]